PMV PHARMACEUTICALS, INC. Other Noncash Income (Expense)
PMV PHARMACEUTICALS, INC. (PMVP) reported Other Noncash Income (Expense) of -$1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$1.00K, a 150.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2025-12-31 was $47.00K.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$1.00K, a 101.69% decline year-over-year.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2025 was $62.00K, a 40.91% increase from fiscal 2024.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2024 was $44.00K.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2022 was $92.00K, a 384.21% increase from fiscal 2021.
- PMV PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2021 was $19.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.00K 10-Q · filed 2026-08-14 | $46.00K derived: sum of 3 quarters · filed 2026-08-14 | $45.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-12 | $46.00K derived: sum of 2 quarters · filed 2026-05-12 | $45.00K derived: sum of 3 quarters · filed 2026-05-12 | $59.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $46.00K derived: sum of 2 quarters · filed 2026-03-06 | $60.00K derived: sum of 3 quarters · filed 2026-08-14 | $62.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $13.00K derived: sum of 2 quarters · filed 2026-08-14 | $15.00K 10-Q · filed 2025-11-12 | $7.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $16.00K 10-Q · filed 2026-08-14 | $8.00K derived: sum of 3 quarters · filed 2026-08-14 | $67.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-12 | -$6.00K derived: sum of 2 quarters · filed 2026-05-12 | $53.00K derived: sum of 3 quarters · filed 2026-05-12 | $54.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $51.00K derived: sum of 2 quarters · filed 2026-03-06 | $52.00K derived: sum of 3 quarters · filed 2026-03-06 | $44.00K 10-K · filed 2026-03-06 |
| 2024-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $60.00K derived: sum of 2 quarters · filed 2025-11-12 | $52.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$7.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$8.00K 10-Q · filed 2025-05-09 | |||
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-09 | $7.00K derived: sum of 2 quarters · filed 2025-03-03 | $5.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.00K derived: sum of 2 quarters · filed 2025-03-03 | $92.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $86.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $88.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $19.00K 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $17.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$100.00K derived: sum of 2 quarters · filed 2023-03-01 | -$138.00K derived: sum of 3 quarters · filed 2023-03-01 | -$143.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$139.00K derived: sum of 2 quarters · filed 2021-11-12 | -$144.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$43.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$5.00K 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | -$8.00K 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $13.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |